We are pleased to share that we will be sponsoring and exhibiting at the 3rd Molecules Medicinal Chemistry Symposium held on 27th-29th July 2022, in Rome, Italy.
Reach out to Claudio Dagostin if you are around!
The 3rd Molecules Medicinal Chemistry Symposium (MMCS2022) is a follow-up to the successful 2nd Molecules Medicinal Chemistry Symposium—Facing Novel Challenges in Drug Discovery (MMCS2019), held in May 2019 in Barcelona, Spain, which is regularly attended by scientists including chemists, biophysicists, structural biologists among others. The aim of this event is to focus on Shaping medicinal chemistry for the new decade of particularly challenging diseases, novel and revisited drug discovery approaches. MMCS22 will also focus on stories about recently implemented projects such as target and hit identification, hit-to-lead optimization, preclinical and clinical development, and more.
o2h discovery is a Contract Research Organisation which has an integrated drug discovery platform operating from our state-of-the-art research centre in India and The Mill SciTech Park, Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development.
For more details about the conference, please visit – https://mmcs2022.sciforum.net/#welcome
To book a meeting with Claudio Dagostin (Director, Business Development at o2h discovery), please click on the given link – https://claudiodagostin.setmore.com/
Or scan the QR code –
